# Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital

**Authors:** Giulia Zorzi, Perrin Ngougni Pokem, Geraldine Dahlqvist, Bénédicte Délire, Nicolas Lanthier, Peter Starkel, Yves Horsmans, Cedric Aupaix, Samia Jnaoui, Damien Gruson

PMC · DOI: 10.3390/diagnostics14171882 · 2024-08-28

## TL;DR

This study evaluates a ten-antigen immunodot test for diagnosing autoimmune liver diseases, finding it to be a quick and accurate alternative to traditional methods.

## Contribution

The study demonstrates the immunodot test's effectiveness in identifying autoantibodies missed by conventional tests, improving diagnostic accuracy.

## Key findings

- The immunodot panel confirmed all positive IIF+ELISA results except for two samples.
- The test identified over 20 additional autoantibodies in initially negative samples.
- The immunodot technique showed high sensitivity, specificity, and overall accuracy.

## Abstract

Autoimmune diseases of the liver and biliary tract require timely and accurate diagnosis. This study evaluates the D-tek panel (D-Tek, Mons, Belgium) of 10 immunodot antigens for its effectiveness in diagnosing autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). We retrospectively analysed serum samples from 111 patients who had undergone routine testing, including indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISA), to confirm or exclude autoimmune liver or biliary tract disease. The panel tested for M2/nPDC, M2/OGDC-E2, M2/BCOADC-E2, M2/PDC-E2, gp210, sp100, LKM1, LC1, SLA, and F-actin antigens. Results showed that all positive IIF+ELISA results were confirmed by the immunodot panel, except for two samples from patients who had never been diagnosed with AIH. The immunodot test identified over 20 additional autoantibodies in samples initially negative by IIF, corroborated by laboratory imaging and medical history. The immunodot technique proved to be a quick, sensitive, and specific method with high overall accuracy. This study suggests that the immunodot technique may be an effective screening and confirmatory method for autoimmune liver diseases, potentially improving diagnostic efficiency and accuracy in clinical practice.

## Linked entities

- **Proteins:** NUP210 (nucleoporin 210), SP100 (SP100 nuclear body protein), DNAL1 (dynein axonemal light chain 1), SLA (Src like adaptor), Act5C (Actin 5C)
- **Diseases:** autoimmune hepatitis (MONDO:0016264), primary biliary cholangitis (MONDO:0005388)

## Full-text entities

- **Genes:** NUP210 (nucleoporin 210) [NCBI Gene 23225] {aka GP210, POM210}, DLAT (dihydrolipoamide S-acetyltransferase) [NCBI Gene 1737] {aka DLTA, E2, PBC, PDC-E2, PDCE2}, SLA (Src like adaptor) [NCBI Gene 6503] {aka SLA1, SLAP}, SP100 (SP100 nuclear body protein) [NCBI Gene 6672] {aka lysp100b}, DBT (dihydrolipoamide branched chain transacylase E2) [NCBI Gene 1629] {aka BCATE2, BCKAD-E2, BCKADE2, BCKDH-E2, BCOADC-E2, E2}, DLST (dihydrolipoamide S-succinyltransferase) [NCBI Gene 1743] {aka DLTS, KGD2, PGL7, PPGL7}
- **Diseases:** autoimmune liver or biliary tract disease (MESH:D001660), PBC (MESH:D008105), Autoimmune diseases of the liver (MESH:D008107), AIH (MESH:D019693)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11394284/full.md

---
Source: https://tomesphere.com/paper/PMC11394284